In 2022, when she was 27 years old, Courtney was diagnosed with acute lymphoblastic leukemia. Just ten years prior, the prognosis for this type of leukemia was only about six months.
If you cut research funding, you are talking about impacting actual people’s lives. To halt innovation and take away clinical trials from people, it’s tough to swallow.
Courtney was able to participate in a clinical trial that ultimately saved her life. The immunotherapy she received through the trial came with significantly fewer side effects and a much shorter treatment time compared to traditional chemotherapy. Thanks to advancements in research and clinical trials, the survival rate for Courtney’s type of cancer is now over 90%.